Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for MIXED SALTS AMPHETAMINE

Ingredient

MIXED SALTS AMPHETAMINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-AMPHETAMINE XR	25MG	CAPSULE (EXTENDED RELEASE)	Resolved	2024-01-12	2024-03-01	215964
APO-AMPHETAMINE XR	20MG	CAPSULE (EXTENDED RELEASE)	Resolved	2022-12-23	2023-03-23	179437
APO-AMPHETAMINE XR	10MG	CAPSULE (EXTENDED RELEASE)	Resolved	2023-09-22	2023-11-17	204987
APO-AMPHETAMINE XR	10MG	CAPSULE (EXTENDED RELEASE)	Resolved	2023-02-23	2023-03-23	185474
APO-AMPHETAMINE XR	5MG	CAPSULE (EXTENDED RELEASE)	Resolved	2025-08-07	2025-11-19	264561
APO-AMPHETAMINE XR	30MG	CAPSULE (EXTENDED RELEASE)	Resolved	2025-08-07	2025-11-21	264573
APO-AMPHETAMINE XR	5MG	CAPSULE (EXTENDED RELEASE)	Resolved	2025-02-13	2025-07-25	250325
APO-AMPHETAMINE XR	5MG	CAPSULE (EXTENDED RELEASE)	Resolved	2024-01-19	2024-02-23	216681
APO-AMPHETAMINE XR	10MG	CAPSULE (EXTENDED RELEASE)	Resolved	2025-08-07	2025-11-19	264564
APO-AMPHETAMINE XR	10MG	CAPSULE (EXTENDED RELEASE)	Resolved	2025-02-27	2025-07-25	251358

Previous
1
2
3
4
5
…
10
Next

Showing 21 to 30 of 93

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ AMPHETAMINE XR	30MG	CAPSULE (EXTENDED RELEASE)	To be discontinued	2025-05-15	2025-05-15	257384

Showing 11 to 11 of 11